First test: how kidneys handle new drug
NCT ID NCT06661733
Summary
This early study aimed to understand how a single dose of an experimental drug, AZD5462, is processed by the body in people with moderate to severe kidney problems. It compared 16 participants with reduced kidney function to healthy volunteers to check for safety and see if the drug behaves differently. The goal was to gather basic information to guide future research, not to treat the kidney disease itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Sofia, 1612, Bulgaria
Conditions
Explore the condition pages connected to this study.